We are live on ! Find out more
Focus Partners Wealth

Focus Partners Wealth Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.5%
This Fund
S&P 500
This Quarter Est. Return
+8.07%
1 Year Est. Return
+20.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$62B
AUM Growth
+$15.8B
Cap. Flow
+$14.2B
Cap. Flow %
22.92%
Top 10 Hldgs %
21.82%
Holding
2,341
New
313
Increased
1,132
Reduced
663
Closed
141

Sector Composition

Rank Sector Weight
1 Technology 12.28%
2 Financials 6.38%
3 Consumer Discretionary 3.98%
4 Communication Services 3.9%
5 Healthcare 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDIT icon
2151
Editas Medicine
EDIT
$402M
$66.9K ﹤0.01%
19,232
-1,580
-8% -$4.41K
EGHT icon
2152
8x8 Inc
EGHT
$271M
$66.8K ﹤0.01%
30,978
-40,948
-57% -$82.3K
BLND icon
2153
Blend Labs
BLND
$433M
$63.3K ﹤0.01%
16,405
-1,832
-10% -$6.58K
ABEV icon
2154
Ambev
ABEV
$48.4B
$61.5K ﹤0.01%
26,962
+7,738
+40% +$17.7K
NAT icon
2155
Nordic American Tanker
NAT
$1.35B
$59.4K ﹤0.01%
18,924
+4,424
+31% +$13.1K
IRWD icon
2156
Ironwood Pharmaceuticals
IRWD
$626M
$58.5K ﹤0.01%
44,652
+10,105
+29% +$10.5K
CMPX icon
2157
Compass Therapeutics
CMPX
$367M
$56K ﹤0.01%
15,805
+2,206
+16% +$6.97K
CURI icon
2158
CuriosityStream
CURI
$145M
$55.1K ﹤0.01%
10,387
-8,000
-44% -$36.9K
AAME icon
2159
Atlantic American Corp
AAME
$32.6M
$52.7K ﹤0.01%
18,335
GALT icon
2160
Galectin Therapeutics
GALT
$223M
$51.9K ﹤0.01%
12,262
-1,054
-8% -$3.96K
FATE icon
2161
Fate Therapeutics
FATE
$270M
$51.2K ﹤0.01%
12,138
-20,578
-63% -$22.2K
NUVB icon
2162
Nuvation Bio
NUVB
$2.33B
$48.9K ﹤0.01%
+13,227
New +$36K
TLRY icon
2163
Tilray
TLRY
$498M
$47.8K ﹤0.01%
2,764
+274
+11% +$2.62K
PLTK icon
2164
Playtika
PLTK
$1.51B
$46.3K ﹤0.01%
11,907
-9,094
-43% -$37.1K
NNDM
2165
Nano Dimension
NNDM
$314M
$43.2K ﹤0.01%
27,500
+4,000
+17% +$5.83K
KULR icon
2166
KULR Technology Group
KULR
$117M
$41.6K ﹤0.01%
+10,000
New +$53.3K
FOXF icon
2167
Fox Factory Holding Corp
FOXF
$801M
$38.3K ﹤0.01%
+10,238
New +$288K
SERA icon
2168
Sera Prognostics
SERA
$79.5M
$37.2K ﹤0.01%
12,156
HCAT icon
2169
Health Catalyst
HCAT
$158M
$36.3K ﹤0.01%
12,522
-9,993
-44% -$34.2K
INO icon
2170
Inovio Pharmaceuticals
INO
$84.7M
$33.4K ﹤0.01%
+14,289
New +$27.4K
DOUG icon
2171
Douglas Elliman
DOUG
$160M
$32.3K ﹤0.01%
11,048
+48
+0.4% +$126
MVIS icon
2172
Microvision
MVIS
$86.6M
$32K ﹤0.01%
25,840
+300
+1% +$357
JOB icon
2173
GEE Group
JOB
$23.1M
$30.8K ﹤0.01%
149,077
+73,993
+99% +$15K
DHF
2174
BNY Mellon High Yield Strategies Fund
DHF
$171M
$30K ﹤0.01%
11,579
+232
+2% +$600
USBC
2175
USBC Inc
USBC
$124M
$29.5K ﹤0.01%
+22,000
New +$39.6K

Similar funds

Focus Partners Wealth's Q3 2025 Portfolio in Review

As of Q3 2025, Focus Partners Wealth held 2,341 positions worth $62B, up 34% from $46.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Focus Partners Wealth deployed $14.2B of net new capital in Q3 2025, opening 313 new positions and adding to 1,132 existing holdings. Its largest new stake was DoubleLine Asset-Backed Securities ETF: 3,380,343 shares worth $631M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Small-Cap Value ETF, an estimated $30.3M trimmed.

  • Focus Partners Wealth's largest Q3 2025 buy was DoubleLine Asset-Backed Securities ETF: 3,380,343 shares worth $631M.
  • Focus Partners Wealth added most to Vanguard Russell 1000 ETF in Q3 2025, an estimated $2.52B increase.
  • Focus Partners Wealth's biggest Q3 2025 reduction was Vanguard Small-Cap Value ETF, cutting an estimated $30.3M.
  • Focus Partners Wealth fully exited State Street SPDR S&P International Dividend ETF in Q3 2025, selling an estimated $6.82M.
  • Focus Partners Wealth's ten largest holdings make up 22% of its $62B portfolio in Q3 2025.
  • Focus Partners Wealth opened 313 new positions and closed 141 in Q3 2025.
  • Focus Partners Wealth's portfolio value rose 34% quarter-over-quarter to $62B.

Based on Focus Partners Wealth's 13F filing for Q3 2025, filed 14 Nov 2025.